Investigation of changes in apelin receptor mRNA and protein expression in the myocardium and aorta of rats with two-kidney, one-clip (2K1C) Goldblatt hypertension

• Hamid Najafipour ^[1] ; Abedin Vakili ^[2] ; Beydolah Shahouzehi ^[1] ; Ava Soltani Hekmat ^[3] ; Yaser Masoomi ^[1] ; Mahbobeh Yeganeh Hajahmadi ^[1] ; Saeed Esmaeli-Mahani ^[4]
  1. [1] Kerman University of Medical Sciences

     Kerman University of Medical Sciences

     Irán

     
  2. [2] Semnan University of Medical Sciences

     Semnan University of Medical Sciences

     Irán

     
  3. [3] Fasa University of Medical Sciences

     Fasa University of Medical Sciences

     Irán

     
  4. [4] Shahid Bahonar University of Kerman

     Shahid Bahonar University of Kerman

     Irán

     

  Mostrar afiliaciones +
• Localización: Journal of physiology and biochemistry, ISSN-e 1877-8755, ISSN 1138-7548, Vol. 71, Nº. 2 (June), 2015, págs. 165-175
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Experimental and clinical evidences suggest that apelin and its receptor APJ are involved in the pathogenesis of cardiovascular complications. However, the role of apelin/APJ in hypertension is not sufficiently understood. Because chronic kidney diseases lead to hypertension and cardiac failure, we investigated the changes in apelin receptor gene expression in the myocardium and aorta of rat models of kidney disease hypertension. Two-kidney, one-clip (2K1C) hypertension was produced by placing a clip around the renal artery. Four and 16 weeks later, blood pressure, left ventricular end-diastolic pressure (LVEDP), serum apelin, and angiotensin II were measured. The messenger RNA (mRNA) and protein of APJ were determined by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. Chronic hypertensive rats had approximately 10 times higher LVEDP (P < 0.001). 2K1C decreased serum apelin from 220 ± 11 to 170 ± 10 pg/mL in 16 weeks (P < 0.05). The mRNA expression of APJ significantly decreased in the heart and aorta at 4 weeks. At 16 weeks, the reduction was not significant in the heart but was significant in the aorta. At 4 weeks, the expression of the APJ protein significantly decreased in the heart but not in the aorta. At 16 weeks, APJ protein was significantly decreased only in the aorta. Reduction of serum apelin and downregulation of apelin receptors in both the heart and aorta may play a role in the pathophysiology of hypertension and cardiac failure in 2K1C hypertensive rats.